Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0S1BN
|
|||
Former ID |
DIB008408
|
|||
Drug Name |
Iptakalim
|
|||
Synonyms |
2,3-Dimethyl-N-isopropyl-2-butanamine hydrochloride
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Hypertension [ICD-11: BA00-BA04; ICD-9: 401] | Phase 1 | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C9H21N
|
|||
Canonical SMILES |
CC(C)C(C)(C)NC(C)C
|
|||
InChI |
1S/C9H21N/c1-7(2)9(5,6)10-8(3)4/h7-8,10H,1-6H3
|
|||
InChIKey |
RGWFHCMKBAMWDX-UHFFFAOYSA-N
|
|||
CAS Number |
642407-44-1
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Potassium channel unspecific (KC) | Target Info | Opener | [1], [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Iptakalim: A novel multi-utility potassium channel opener. J Pharmacol Pharmacother. 2012 Jan;3(1):12-4. | |||
REF 2 | Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 2012 Jan;40(Database issue):D1128-36. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.